DIRS.INFO The most relevant business & tech news

☆ Lightning Round: Right now is when you start buying Oracle, says Jim Cramer
▼ + stars: | 2023-08-09 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Right now is when you start buying Oracle, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stocks including: Medtronic, Public Service, Fisker, Adtran, Marvell, Con Ed and Oracle.

Persons: Jim Cramer, Con Ed Organizations: Oracle, Public Service, Marvell

☆ Cramer's Lightning Round: Oracle is a buy
▼ + stars: | 2023-08-09 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Medtronic's year-to-date stock portfolio. Stock Chart Icon Stock chart icon Fisker's year-to-date stock portfolio. Stock Chart Icon Stock chart icon Adtran's year-to-date stock performance. Stock Chart Icon Stock chart icon Marvell's year-to-date stock performance. Stock Chart Icon Stock chart icon Oracle's year-to-date stock performance.

Persons: It's, Con, Con Edison, We've, Jeff Organizations: GE Healthcare, Enterprise, Public Service Enterprise, Marvell, Oracle

☆ Elon Musk is 'totally out of his element' at Twitter because he doesn't 'understand social media,' a Harvard leadership expert says
▼ + stars: | 2023-07-28 | by ( Sawdah Bhaimiya | ) www.businessinsider.com time to read: +3 min

A Harvard leadership expert thinks Elon Musk is "totally out of his element" in running Twitter. He explained that the billionaire doesn't have any expertise of running a social media platform. A Harvard leadership expert weighed in on Elon Musk's takeover of Twitter and the changes he's made, saying that the billionaire is "totally out of his element" because social media is not his area of expertise. George suggested that Musk should let Twitter's new CEO Linda Yaccarino call the shots. William Klepper, a management professor teaching an executive leadership course at Columbia Business School, previously told Insider that Musk's Twitter takeover is "a case study of failed leadership."

Persons: Elon Musk, doesn't, Bill George, Elon, George, Musk, Parag Agrawal, Ned Sagal, Vijaya Gadde, Sean Edgett, Linda Yaccarino, William Klepper, Klepper Organizations: Harvard, Twitter, Harvard Business School, CNBC, SpaceX, Columbia Business School Locations: Elon Musk's

Abbott CEO Robert Ford said the great momentum in device and diagnostics sales during the quarter was due to improving market conditions in healthcare. Rival J&J's (JNJ.N) medical device segment also topped estimates, aided by a recovery in demand for medical procedures. Shares of rival medical device makers Medtronic (MDT.N) and Boston Scientific Corp (BSX.N) rose nearly 3%. Abbott clocked quarterly sales for its medical devices at $4.3 billion, with $1.3 billion coming from diabetes device Freestyle Libre, beating analysts' estimates of $4.10 billion. Abbott's adjusted profit of $1.08 per share in the quarter beat analysts' estimates of $1.05.

Persons: Robert Ford, J, Shagun Singh, Abbott, Khushi Mandowara, Pooja Desai Organizations: Abbott Laboratories, RBC Capital Markets, Boston Scientific Corp, U.S, Thomson Locations: Michigan, Bengaluru

☆ Post-it maker 3M is in danger of coming unstuck
▼ + stars: | 2023-07-19 | by ( Jeffrey Goldfarb | ) www.reuters.com time to read: +10 min

There will be up to $1.5 billion of costs related to separating the health care business, 3M has said. Its interest cover, after backing out estimated operating income from health care, would fall to about 4 times from 11 times. And its net debt, using all these assumptions and excluding the health care division, would swell to nearly 5 times EBITDA from less than 2 times. Back out $2.5 billion from health care, as estimated by the Morgan Stanley team, and $1.5 billion of capital expenditure costs noted by Wolfe Research. For example, the water settlement, as drafted, only envisions $4.6 billion of outlays through 2025, and the rest over the ensuing 11 years.

Persons: Mike Roman, Roman, Sackler, Johnson, Aearo, ”, Morgan Stanley, Smith, Nephew, Lauren Silva Laughlin, Streisand Neto Organizations: YORK, Reuters, U.S . Environmental, Purdue Pharma’s, Association of Metropolitan Water Agencies, Bayer, Monsanto, Aearo Technologies, Partners, Honeywell International, Siemens, 3M, Refinitiv, Reuters Graphics, Wolfe Research, Thomson Locations: . Oregon, Republic, Corning

Tom Schroeder, the whistleblower accusing Medtronic of a kickback scheme, left, is interviewed by Morgan Brennan, in Kansas City, Missouri. Schroeder said rumors circulated that Medtronic sales representatives were bribing VA staff to purchase an excessive amount of the company's inventory. The veterans hospital purchased more devices than some of the largest veterans medical facilities, according to data the VA's investigation gathered. Medtronic also said that Schroeder has "admitted under oath that he has no firsthand knowledge of any problematic procedure involving Medtronic devices." Douglas Winger, one of the Medtronic sales representatives named as a defendant in Schroeder's lawsuit, won a Medtronic President's Club award in 2016 for his sales.

Persons: Tom Schroeder, Schroeder, Becton Dickinson, Medtronic, Morgan Brennan, Schroder, Boua Xiong, Robert J, texted, Rick Ament, Ament, filet mignon, …, I'm, Brendan Donelon, Donelon, CNBC Donelon, Xiong, Douglas Winger, Winger, Kim Hodgson, Hodgson, Dole, ProPublica, John Laird Organizations: Inc, CNBC, Dole Veterans Affairs Medical Center, Dole VA, Department of Veterans Affairs, United, VA's, Department of Justice, Covidien, Dole, Medtronic, Society for Vascular, Drug Administration, FDA Locations: Kansas, United States, Kansas City , Missouri, Dublin, Ireland, Medtronic's, Wichita ., Dole, Covidien, Medtronic, Dole VA

☆ A son died, his parents tried to sue. How U.S. courts protect Big Pharma
▼ + stars: | 2023-06-26 | by ( ) www.reuters.com time to read: +26 min

His parents soon started exploring a lawsuit against Merck, the developer of the blockbuster asthma and allergy drug, Singulair, along with the manufacturer of the generic version their son took. That meant Merck had written the warning label, with federal approval, on the generic version of Singulair that Nicholas England took. But his parents couldn’t sue Merck, either, because their son had never taken its name-brand version of Singulair. The generic drug manufacturer that made the pills England took, Teva Pharmaceuticals, did not respond to inquiries. Since Merck’s patent on Singulair expired in 2012, major generic drug manufacturers have sold millions of prescriptions under the drug’s scientific name, montelukast.

Persons: Nicholas England, Nicholas, Merck, ”, Jennifer England, Nicholas’s, ” Merck, Organon, “, George W, Bush, Daniel Troy, Troy, Medtronic, Nicholas England’s, Adam Zimmerman, ” Zimmerman, Jay Lefkowitz, Ellis, shouldn’t, Bayer, drugmaker Wyeth, Phenegran, Jan Gilpin’s, mumbling, ” Gilpin, ” “, hadn’t, Singulair, Gilpin, Stephane Bissonnette, suicidality, Dr, Judith Kramer, Duke, Robert England, Robert said, Kim Beck Organizations: Merck, U.S, Teva Pharmaceuticals, Reuters, U.S . Food, Drug Administration, FDA, Big, Corporate America, Corporations, Administration, ”, New, University of Southern California’s Gould School of Law, Norfolk, Union Pacific, Federal Railroad Safety, Pacific, GlaxoSmithKline, Monsanto, Bayer, Parent Locations: Virginia, England, U.S, New York, Kirkland, East Palestine , Ohio, Louisiana, Atlanta, Vermont, Wise , Virginia, Wisconsin

☆ These medical device makers are driving a 'paradigm' shift in cardiac care, Piper Sandler says
▼ + stars: | 2023-06-19 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for medical device companies Boston Scientific and Medtronic, according to Piper Sandler analyst Matt O'Brien. He estimates that Boston Scientific will ring up $454 million in sales by 2025 for its Farapulse catheter. Meanwhile, Boston Scientific shares hit a record high on Friday. BSX YTD mountain Boston Scientific shares have gained more than 17% so far this year. He expects that this could prompt consolidation, providing a way for any larger AF treatment providers that have fallen behind on innovation to catch up.

Persons: Piper Sandler, Matt O'Brien, O'Brien, Medtronic, Medtronic's, Abbott, Johnson Organizations: Boston Scientific, Centers for Disease Control, PFA, Boston, EU Locations: U.S

☆ An ETF focused on the 'moats' strategy of Warren Buffett is beating the market once again
▼ + stars: | 2023-06-16 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +3 min

An exchange traded fund built on an investing strategy popularized by Warren Buffett is proving its worth once again in 2023. The VanEck Morningstar Wide Moat ETF (MOAT) has a total return of more than 23% year to date, according to FactSet, handily beating the S & P 500 and enhancing an already stellar long-term track record. MOAT 5Y mountain The VanEck Morningstar Wide Moat ETF has been a long-term outperformer. The Vanguard Value ETF (VTV) and iShares Core S & P 500 ETF (IVV) were the top two funds of the week, each bringing in more than $2 billion. Several large short-term bond funds saw outflows this week, including Vanguard Short-Term Bond ETF (BSV) .

Persons: Warren Buffett, FactSet, Brandon Rakszawski, Rakszawski, It's Organizations: Morningstar, Adobe, Bond, Federal Locations: VanEck, outflows

☆ Health insurance stocks slide after UnitedHealth warns more surgeries will drive up medical costs
▼ + stars: | 2023-06-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Health insurer stocks dropped on Wednesday after UnitedHealth Group warned of higher medical costs as older Americans start to catch up on surgeries they delayed during the Covid pandemic. Shares of UnitedHealth, the largest U.S. healthcare provider by market value, closed around 6% lower. Elevance Health closed roughly 7% lower, and CVS Health , which owns the insurer Aetna, slid nearly 8%. The company has recorded "strong outpatient care activity" throughout April, May and the early part of June, CFO John Rex said at a Goldman Sachs healthcare conference. Shares of medical device manufacturers Medtronic and Stryker jumped 2.5% and 4%, respectively, after UnitedHealth's remarks.

Persons: UnitedHealth, John Rex, Goldman Sachs, Medicare enrollees, Rex, Timothy Noel, Stryker, UnitedHealth's Organizations: UnitedHealth, Medicare, Humana, Elevance Health, CVS Health, Aetna, Insurance, Goldman, Healthcare, Tenet Healthcare

☆ One of America's biggest health insurers just issued a warning that healthcare costs are about to soar
▼ + stars: | 2023-06-14 | by ( Lydia Ramsey Pflanzer | ) www.businessinsider.com time to read: +2 min

An insurance exec warned of higher medical costs as Americans start to get more elective procedures. It suggests people are getting care they put off during the height of the pandemic. Older Americans are starting to get more procedures like hip and knee surgeries, and it's driving up how much one of the biggest US health insurers is spending on medical care. The "strong" level of care older Americans are seeking out suggests that people are getting more comfortable getting procedures they put off during the pandemic, the UnitedHealth Group executive said. The stocks of health insurance companies tumbled on Wednesday following the warning.

Persons: John Rex, Goldman, Jodi Jacobson, Stryker, Medtronic Organizations: UnitedHealth, UnitedHealth Group, CVS Health, Tenet Locations: Goldman Sachs, Aetna

☆ Final Trades: Medtronic, Merck, The Williams Cos. & more
▼ + stars: | 2023-05-31 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: Medtronic, Merck, The Williams Cos. & moreThe "Halftime Report" traders give their top picks to watch for the second half.

Persons: Williams Cos Organizations: Merck

☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Ford, Wayfair, Coinbase, Disney, PayPal & more
▼ + stars: | 2023-05-30 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Barclays reiterates Tesla as overweight Barclays said the stock is well positioned for more gains. "The dominant narrative ahead for Tesla is one of growth, with expectations for significant volume growth and share gains in the years ahead." Roth MKM upgrades Constellation Brands to buy from hold Roth MKM said it sees the company accelerating market share gains. "As weather warms, we expect the share gains for Modelo Especial and Corona to accelerate. Morgan Stanley upgrades Medtronic to overweight from equal weight Morgan Stanley said in its upgrade of Medtronic that it's turning an operational corner. "

With the end of another earnings season in sight, Wall Street's attention has turned to Washington and the debt ceiling deadline. Republican negotiators on Friday walked out of talks on raising the debt limit , abruptly ending a positive week of discussions that appeared to be leading toward a deal. Democrats and the White House have been pushing for a "clean" hike to the debt limit that would push the next deadline past the 2024 presidential election, while Republicans are pressing for spending cuts. Many investors believe this ongoing game of chicken over the debt limit is largely for show, since the U.S. has never defaulted on its debt obligations. U.S. President Joe Biden hosts debt limit talks with House Speaker Kevin McCarthy (R-CA) and other congressional leaders in the Oval Office at the White House in Washington, U.S., May 9, 2023.

☆ A number of outperforming stocks have bucked macro trends, Jim Cramer says
▼ + stars: | 2023-05-08 | by ( Rohan Goswami | In Rohangoswamicnbc | ) www.cnbc.com time to read: +1 min

Investors should be wary of bearish strategists who opt for a macro view and instead focus on individual companies, CNBC's Jim Cramer said Monday. In a market where idiosyncratic performers are plentiful, following one-size-fits-all macro advice can leave investors confused, Cramer says. Cramer pointed to outsize performers in myriad industries that would have been written off by those same bearish strategists. Investors might expect that industrial and homebuilding stocks would be suffering given the continued rate hikes, Cramer said. But industrial names like General Electric or Cummins have done extremely well, as have housing stalwarts like KB Home and Lennar , Cramer said.

The buyout consortium has turned to other private equity firms to help fund the deal as direct lenders, one of the sources added. There is no certainty that Warburg Pincus and Advent will successfully complete negotiations to acquire the unit and Baxter may still opt to sell to another bidder or keep the business, according to the sources. Baxter, Warburg and Advent did not immediately respond to requests for comment. Baxter's biopharma solutions unit supports drugmakers in the formulation, development and commercialization of drugs typically given by infusion or injection, such as biologics and vaccines. The company said dialysis operations, which are a part of Baxter's renal care unit, had become a drag on its margin.

☆ Wells Fargo upgrades this medical device maker, cites improving industry trends
▼ + stars: | 2023-04-24 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Analyst Larry Biegelsen upgraded the medical device maker to overweight from equal weight in a Sunday note, saying that shares should benefit from improving medtech trends and a "maturing" product pipeline. "We rate MDT Overweight as we believe that the company will benefit as underlying medtech markets improve as staffing shortages ease in major markets," he said. Within the company's product pipeline, Biegelsen sees the biggest potential upside from the U.S. Food and Drug Administration's approval of its upgraded insulin pump known as 780G. According to Biegelsen, Medtronic's valuation also looks attractive, trading at a sharp discount to peers. "We believe once MDT moves past its FY2024 guidance in May, the stock can re-rate on the overall medtech recovery and product pipeline," he wrote.

☆ Stocks making the biggest moves midday: Fox, Albemarle, First Republic and more
▼ + stars: | 2023-04-24 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

People walk by the News Corporation headquarters, home to Fox News, on April 18, 2023 in New York City. First Solar – Shares of the solar company lost 3.2% after a Citi downgrade to sell cited margin risks and concerns that Inflation Reduction Act benefits are already reflected in the share price. Medtronic — Shares added 4% during midday trading after being upgraded to overweight from equal weight by Wells Fargo on Sunday. Sunrun , Enphase Energy — Shares of Sunrun and Enphase Energy were higher Monday after Citi added positive catalyst watches on the solar companies, saying it sees further share gains. The Wall Street bank opened a 90-day positive catalyst watch on Enphase Energy, citing a strong backlog and expectations for record-high margins.

☆ Here are Monday's biggest analyst calls: Apple, Amazon, Chipotle, Ford, Disney, Nvidia, Sunrun & more
▼ + stars: | 2023-04-24 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

"We upgrade ALLY to Neutral (from Underperform) and raise our PO to $28 from $24, implying ~8% upside potential." Goldman Sachs reiterates Apple as buy Goldman said in its Apple earnings preview note that "solid iPhone demand to offset Mac weakness." Wells Fargo names Disney a top pick in media Wells said in a note on Monday that Disney is the "best opportunity in media." JPMorgan reiterates Ford & General Motors as overweight JPMorgan said in an earnings preview note that it's standing by both automakers heading into earnings tomorrow for GM and next week for Ford . Mizuho initiates Tencent Music Entertainment as buy Mizuho said in its initiation of the China music company that the stock has upside potential. "

☆ Stocks making the biggest premarket moves: Coca-Cola, First Solar, C3.ai and more
▼ + stars: | 2023-04-24 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

First Solar — Shares dropped 2.5% in the premarket following a downgrade by Citi to sell from neutral. Credit Suisse — U.S.-listed shares of the Swiss bank gained about 2% in the premarket. Credit Suisse said it experienced net asset outflows of 61.2 billion Swiss francs ($68 billion) during the first quarter. However, it reported 12.43 billion Swiss franc profit for the quarter thanks to the write-off of 15 billion Swiss francs of AT1 bonds. Albemarle — Shares of the mining company gained nearly 3% in premarket trading, trimming Albemarle's losses from last week.

☆ Here are the top 15 companies to work for in Singapore, according to LinkedIn — most are new on the list
▼ + stars: | 2023-04-18 | by ( Goh Chiew Tong | ) www.cnbc.com time to read: +4 min

The list of top companies in Singapore sees a huge reshuffle this year, which is a testament to "Singapore's strong business ecosystem," according to LinkedIn. LinkedIn has released its annual list of top companies in Singapore to work for — and banking and information technology companies dominated the 2023 list. The list of top companies also saw a huge reshuffle this year, which is a testament to "Singapore's strong business ecosystem," according to the professional networking platform. The banking and finance sector in particular, saw 4 companies in the top 5 on the "LinkedIn Top Companies 2023″ for Singapore. It provides financial products and banking services to individuals, corporations, governments, investors and institutions.

☆ Intuitive Surgical beats first-quarter sales on higher procedure volumes
▼ + stars: | 2023-04-18 | by ( Sriparna Roy | ) www.reuters.com time to read: +2 min

April 18 (Reuters) - Intuitive Surgical Inc (ISRG.O) beat estimates for first-quarter sales on Tuesday as the surgical robot maker recorded a rise in total procedure volumes. The company reported quarterly sales of $1.70 billion, beating analysts' estimates of $1.60 billion, according to IBES Refinitiv data. The medical device maker posted a 26% growth in procedure volumes of its surgical robot da Vinci in the first quarter through March from a year earlier. Investors are eyeing the launch of company's new multiport surgical robot, which could be a potential near-term catalyst, analysts said after Intuitive in January told its next generation system is not expected to be launched this year. Excluding items, Intuitive earned $1.23 per share in the first quarter, above analysts' average estimate of $1.20 per share, according to IBES data from Refinitiv.

☆ Strong management can help companies 'change their stripes,' Jim Cramer says
▼ + stars: | 2023-04-06 | by ( Rohan Goswami | ) www.cnbc.com time to read: +2 min

Strong management can make all the difference for a company to "change their stripes" in a corporate pivot, CNBC's Jim Cramer said on Thursday. Cramer pointed to Costco as a prime example of the difference capable management can make. A bevy of other, non-retail companies are suffering as well, Cramer said, including medical-technology company Medtronic and industrial concern 3M . There's hope in the food companies, Cramer noted, pointing to stark evolutions from JM Smucker and Campbell Soup , both of which have rebalanced towards snack foods. But at a well-managed company like Costco, Cramer has no concerns.

☆ Exclusive: ICU Medical to compete against GE Healthcare for Medtronic units -sources
▼ + stars: | 2023-03-29 | by ( David Carnevali | ) www.reuters.com time to read: +2 min

GE Healthcare and private equity firms Carlyle Group Inc (CG.O) and Clayton, Dubilier & Rice (CD&R), which have been pursuing rival offers separately, are also through to the second round, the sources added. Carlyle is bidding through its newly formed healthcare investment platform Atmas Health, according to one of the sources. Medtronic has been taking offers for its patient monitoring and respiratory interventions businesses even as it presses on with preparations to spin them off to its shareholders. ICU Medical, GE Healthcare, Carlyle and CD&R declined to comment. The patient monitoring technology portfolio includes Nellcor pulse oximetry and BIS brain monitoring, while the respiratory interventions business comprises ventilators and breathing systems.

☆ Here are Wednesday's biggest analyst calls: Micron, Meta, McDonald's, Tesla, Apple, Amazon & more
▼ + stars: | 2023-03-29 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Goldman Sachs upgrades Hartford to buy from neutral Goldman the insurance company could "surprise to the upside." Goldman Sachs upgrades Marathon Petroleum to buy from neutral Goldman said the petroleum company has a "best-in-class capital returns story." Bernstein reiterates Apple as market perform Bernstein said it's standing by its market perform rating after Apple debuted Apple Pay Later on Tuesday. Guggenheim reiterates McDonald's as buy Guggenheim says it sees "substantial" near-term and long-term upside for McDonald's. Goldman Sachs reiterates Regions Financial and Fifth Third as buy Goldman said in a note Wednesday that several regional banks are key beneficiaries of the larger bank fallout.

Search resuls for: "Medtronic"

25 mentions found